MENU
VIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vir Biotechnology (VIR) Earnings Date & Reports

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases... Show more

A.I. Advisor
published Earnings

VIR is expected to report earnings to fall 37.07% to -73 cents per share on February 19

Vir Biotechnology VIR Stock Earnings Reports
Q4'25
Est.
$-0.74
Q3'25
Missed
by $0.33
Q2'25
Missed
by $0.10
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.11
The last earnings report on November 05 showed earnings per share of -116 cents, missing the estimate of -83 cents. With 1.13M shares outstanding, the current market capitalization sits at 761.01M.
View a ticker or compare two or three
VIR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VIR showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio